Hong Kong leads global conversation on healthcare innovation at ASGH 2025

[The content of this article has been produced by our advertising partner.]

When a single connection at the Asia Summit on Global Health (ASGH) 2024 helped Eieling Technology secure its partnership in Indonesia, it created ripple effects that continue to expand. The Hong Kong-based medtech company's portable liver scanner has since been adopted in regional hospitals, obtained crucial regulatory approvals, and attracted strategic investors - all through relationships initiated at ASGH. Their journey from university lab to international markets exemplifies why this summit has become Hong Kong's premier platform for healthcare innovation.

This legacy of transformation continues as the city prepares to host ASGH 2025 from May 26 to 27 at the Hong Kong Convention and Exhibition Centre. Jointly organised by the Government of the Hong Kong Special Administrative Region and the Hong Kong Trade Development Council (HKTDC), this year's summit under the theme "Fostering Global Collaboration for a Shared Future" builds on Hong Kong's unique position as a global healthcare hub. Here, where East meets West and innovation meets implementation, the summit will again convene world-class researchers, healthcare business leaders and investors for two days of groundbreaking discussions and strategic connections.

The opening day will feature two plenary sessions. The “Shaping a More Equitable and Sustainable Health System” session will explore the pressing need for health systems that are both equitable and sustainable.

The discussion between Prof Tsui Lap-Chee, Chairman of The University of Hong Kong Foundation for Educational Development and Research, Dr Victor Melt Campos, Chair of APEC Health Working Group, Prof Nancy Ip, President of The Hong Kong University of Science and Technology, Mr Frédéric Rimattei, Special Envoy for International Affairs of the President of the University Hospitals National Association, and more distinguished speakers, will touch upon the integration of technology to enhance accessibility to healthcare, improve efficiency and promote sustainability, while placing the importance of cross-sector collaboration.

The second session, “Fostering Global Collaboration for a Shared Future”, will address the imperative of global collaboration in healthcare innovation. Ambassador George Hara, Group Chairman and CEO of DEFTA Partners, Dr Prem Kumar Nair, Group Chief Executive Officer of IHH Healthcare Berhad, and Dr Hiroaki Ueno, Representative Director, Mitsubishi Tanabe Pharma Corporation will share their insights on latest investment and market opportunities in healthcare, as well as partnerships and strategies to facilitate international research and development, with other eminent speakers during the discussion.

Another highlight of the first day is a special dialogue with Professor John Hardy, the distinguished neuroscientist whose pioneering work on Alzheimer’s disease has transformed our understanding of neurodegenerative disorders.  

Moderated by Victor Chu, the conversation is expected to delve into the breakthroughs that led to Professor Hardy receiving the prestigious Brain Prize in 2018 and a knighthood in 2022 for his contributions to human health. 

With the country’s ambitious Healthy China 2030 blueprint serving as a long-term roadmap, another key session, titled "Beyond ‘Healthy China 2030’: Driving Health Innovation ", will gather speakers from Merck, iCarbonX, Biomap, Hengrui and HSBC to explore the latest innovations and vast investment prospects arising from China’s healthcare transformation, and discuss opportunities for international collaboration and knowledge exchange.